Succinylcholine chloride

ADVERTISEMENT

Identification

Molecular formula
C14H30BrN2O3
CAS Number
71-27-2
IUPAC Name
diethyl-[2-[[2-hydroxy-2-phenyl-2-(2-thienyl)acetyl]-methyl-amino]ethyl]-methyl-ammonium;bromide
Molecular Weight
290.25g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2000g/cm3
Synonyms
FC 108
Interesting facts

Interesting Facts about Diethyl-[2-[[2-hydroxy-2-phenyl-2-(2-thienyl)acetyl]-methyl-amino]ethyl]-methyl-ammonium Bromide

This unique compound, often referred to simply as a quaternary ammonium salt, has garnered attention in the field of medicinal chemistry due to its intriguing structure and potential applications. Here are some fascinating aspects:

  • Complex Structure: The molecule features a complex arrangement with a thienyl moiety and a phenyl group, which can contribute to its biological activity. This structural diversity can lead to multifaceted interactions with biological targets.
  • Pharmacological Potential: Compounds of this nature are often explored for their potential use in drug designs, particularly in the development of antibacterial and antifungal agents.
  • Bioavailability: The presence of both hydroxy and methylamino groups in the structure may enhance the compound's solubility and permeability, facilitating better bioavailability when absorbed in biological systems.
  • Research Relevance: Scientists are increasingly studying quaternary ammonium compounds due to their applications in drug delivery systems, as they can effectively cross biological membranes and interact with various receptors.

In summary, diethyl-[2-[[2-hydroxy-2-phenyl-2-(2-thienyl)acetyl]-methyl-amino]ethyl]-methyl-ammonium bromide stands out not just for its intricate design, but also for its potential in advancing pharmaceuticals. As one researcher aptly put it, "The key to innovative medicines often lies in the exploration of the unforeseen capabilities of existing compounds."
Understanding such compounds opens doors to new therapeutic strategies, making them a rich area for future investigations.

ADVERTISEMENT